Rajesh K. Malik
Chief Tech/Sci/R&D Officer at G1 THERAPEUTICS, INC.
Net worth: 259 824 $ as of 29/04/2024
Rajesh K. Malik active positions
Companies | Position | Start | End |
---|---|---|---|
G1 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/06/2014 | - |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Director/Board Member | 30/04/2018 | - |
Career history of Rajesh K. Malik
Former positions of Rajesh K. Malik
Companies | Position | Start | End |
---|---|---|---|
POIT BIOP | Director/Board Member | 29/06/2021 | 26/12/2023 |
Independent Dir/Board Member | 29/06/2021 | 26/12/2023 | |
AGENNIX AG | Director/Board Member | 31/12/2006 | 31/12/2012 |
Chief Tech/Sci/R&D Officer | 31/12/2006 | 31/12/2012 | |
FENNEC PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 31/08/2004 | 31/12/2006 |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Director/Board Member | 31/12/2001 | 31/12/2003 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/1999 | 31/12/2001 |
University of Virginia | Corporate Officer/Principal | - | - |
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 31/12/2006 | - |
Training of Rajesh K. Malik
University of Sheffield Medical School | Doctorate Degree |
Statistics
International
United States | 9 |
Germany | 2 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
FENNEC PHARMACEUTICALS INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
G1 THERAPEUTICS, INC. | Health Technology |
POIT BIOP | Health Technology |
Private companies | 4 |
---|---|
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Health Technology |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
Agennix AG
Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Health Technology |
- Stock Market
- Insiders
- Rajesh K. Malik
- Experience